This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Why Pediatrix Medical Group (MD) is a Top Value Stock for the Long-Term
by Zacks Equity Research
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Danaher Gains From Strength in the Diagnostics Unit Amid Headwinds
by Zacks Equity Research
DHR is poised to gain from strength in the clinical diagnostics business, the Abcam buyout and shareholder-friendly policies. Softness in Life Sciences and Biotechnology units remains a concern.
Here Is Why Bargain Hunters Would Love Fast-paced Mover Pediatrix Medical Group (MD)
by Zacks Equity Research
If you are looking for stocks that have gained strong momentum recently but are still trading at reasonable prices, Pediatrix Medical Group (MD) could be a great choice. It is one of the several stocks that passed through our 'Fast-Paced Momentum at a Bargain' screen.
MD vs. HQY: Which Stock Is the Better Value Option?
by Zacks Equity Research
MD vs. HQY: Which Stock Is the Better Value Option?
Here's Why Pediatrix Medical Group (MD) is a Strong Momentum Stock
by Zacks Equity Research
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Zacks.com featured highlights include HIS, ANI Pharmaceuticals, Pediatrix Medical, Fresenius Medical Care and LendingTree
by Zacks Equity Research
HIS, ANI Pharmaceuticals, Pediatrix Medical, Fresenius Medical Care and LendingTree are part of the Zacks Screen of the Week article.
5 Relative Price Strength Stocks to Navigate Today's Market
by Nilanjan Choudhury
IHS, ANIP, MD, FMS and TREE are five stocks with explosive relative price strength.
Zacks Industry Outlook Highlights Cencora, Doximity and Pediatrix Medical
by Zacks Equity Research
Cencora, Doximity and Pediatrix Medical are part of the Zacks Industry Outlook article.
3 Medical Services Industry Stocks to Buy as AI Fuels Growth
by Urmimala Biswas
The Zacks Medical - Services industry is undergoing a transformation on massive artificial intelligence adoption. COR, DOCS and MD are set to gain the most. Healthcare staffing shortages are leading to an increase in labor wages.
Are You a Value Investor? This 1 Stock Could Be the Perfect Pick
by Zacks Equity Research
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
UnitedHealth's Optum Rx & EPN Team Up for Fairer Pharmacy Payments
by Zacks Equity Research
UNH and EPN join forces to enhance pharmacy reimbursement, ensuring fair payments and better stability for independent pharmacies.
Humana's CenterWell Launches Gladstone Walmart Location for Seniors
by Zacks Equity Research
The easy accessibility for patients will give HUM a competitive edge over other senior-focused healthcare providers.
Wall Street Analysts Think Pediatrix Medical Group (MD) Could Surge 27.97%: Read This Before Placing a Bet
by Zacks Equity Research
The consensus price target hints at a 28% upside potential for Pediatrix Medical Group (MD). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
Encompass Health Expands Partnership With Piedmont in Georgia
by Zacks Equity Research
EHC and Piedmont expand their partnership with a new rehab hospital in Athens, enhancing patient recovery services.
Molina Healthcare Expands Presence With Illinois D-SNP Contract Win
by Zacks Equity Research
MOH secures a key Illinois contract, strengthening its foothold in the dual-eligible market.
Humana & Icon Enhance Senior Healthcare With Integrated Specialty Care
by Zacks Equity Research
HUM's CenterWell and Conviva partner with Icon Health, improving musculoskeletal care access for seniors.
Fast-paced Momentum Stock Pediatrix Medical Group (MD) Is Still Trading at a Bargain
by Zacks Equity Research
Pediatrix Medical Group (MD) could be a great choice for investors looking to buy stocks that have gained strong momentum recently but are still trading at reasonable prices. It is one of the several stocks that made it through our 'Fast-Paced Momentum at a Bargain' screen.
MD vs. HQY: Which Stock Should Value Investors Buy Now?
by Zacks Equity Research
MD vs. HQY: Which Stock Is the Better Value Option?
Teladoc Expands Specialty Care Access With Carrum Health Partnership
by Zacks Equity Research
TDOC partners with Carrum Health in a bid to expand access to specialty care.
Here's What Brookdale's Occupancy Growth Story Tells Us
by Zacks Equity Research
BKD is likely to have witnessed 40 straight months of year-over-year increases in weighted average occupancy.
Teladoc Doubles Down on Connected Care With New Partnerships
by Zacks Equity Research
With more than 93 million members, deeper integration of services could lead to higher utilization for TDOC.
Here's Why You Should Avoid Betting on Danaher Stock Right Now
by Zacks Equity Research
Persistent softness in the Life Sciences segment weighs on DHR's performance. An increase in operating expenses is an added concern.
Why Pediatrix Medical Group (MD) is a Top Momentum Stock for the Long-Term
by Zacks Equity Research
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Cencora, Inc. (COR) Hits Fresh High: Is There Still Room to Run?
by Zacks Equity Research
Cencora (COR) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Pediatrix Medical Stock Rallies 37.7% in 6 Months: More Room to Run?
by Zacks Equity Research
MD is expected to benefit from rising patient volumes, a favorable payer mix and streamlining initiatives.